Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial

被引：5

作者：

Garcia-Ruiz, Alonso ^{[1
]}

Macarro, Carlos ^{[1
]}

Zacchi, Francesca ^{[1
,2
,3
,4
]}

Morales-Barrera, Rafael ^{[1
,2
]}

Grussu, Francesco ^{[1
]}

Casanova-Salas, Irene ^{[1
]}

Sanguedolce, Francesco ^{[5
,6
]}

Gonzalez, Macarena ^{[1
,2
]}

Cresta-Morgado, Pablo ^{[1
,2
]}

de Albert, Matias ^{[2
]}

Garcia-Bennett, Josep

Marmolejo, David ^{[1
,2
]}

Planas, Jacques ^{[2
]}

Roche, Sarai ^{[2
]}

Mast, Richard ^{[2
]}

Zatse, Christina ^{[1
]}

Piulats, Josep M. ^{[7
,8
]}

Herrera-Imbroda, Bernardo ^{[9
,10
]}

Regis, Lucas ^{[2
]}

Agundez, Laura ^{[1
]}

Olmos, David ^{[11
,12
]}

Calvo, Nahum ^{[7
]}

Escobar, Manuel ^{[2
]}

Carles, Joan ^{[1
,2
]}

Mateo, Joaquin ^{[1
,2
]}

Perez-Lopez, Raquel ^{[1
]}

机构：

[1] Vall dHebron Inst Oncol, Barcelona, Spain

[2] Vall dHebron Univ Hosp, Barcelona, Spain

[3] Univ Verona, Dept Engn Innovat Med, Sect Innovat Biomed Oncol, Verona, Italy

[4] Univ & Hosp Trust Verona, Verona, Italy

[5] Inst Recerca St Pau, Fundacio Puigvert, Barcelona, Spain

[6] Univ Sassari, Dept Med Surg & Pharm, Sassari, Italy

[7] Bellvitge Univ Hosp, Lhospitalet De Llobregat, Spain

[8] Inst Catala Oncol, Lhospitalet De Llobregat, Spain

[9] Hosp Univ Virgen Victoria, Malaga, Spain

[10] Inst Invest Biomed Malaga Plataforma Bionand, Malaga, Spain

[11] Hosp Doce Octubre, Madrid, Spain

[12] Inst Invest i 12, Madrid, Spain

来源：

EUROPEAN UROLOGY | 2024年 / 86卷 / 03期

关键词：

D O I：

10.1016/j.eururo.2024.02.016

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：272 / 274

页数：3

共 50 条

[1] Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response
Parker, Chris
Tunariu, Nina
Tovey, Holly
Alonzi, Roberto
Blackledge, Matthew D.
Cook, Gary J. R.
Chua, Sue
Du, Yong
Hafeez, Shaista
Murray, Iain
Padhani, Anwar R.
Staffurth, John
Tree, Alison
Stidwill, Helen
Finch, Jessica
Curcean, Andra
Chatfield, Peter
Perry, Sophie
Koh, Dow-Mu
Hall, Emma
[J]. JNCI CANCER SPECTRUM, 2023, 7 (06)
[2] Re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2024.02.016
Padhani, Anwar R.
Lecouvet, Frederic
Petralia, Giuseppe
Koh, Dow-Mu
[J]. EUROPEAN UROLOGY, 2024, 86 (03) : e67 - e68
[3] PROMPTS Trial: Screening spinal magnetic resonance imaging in castration-resistant prostate cancer
Pattnaik, Soumya Shivasis
[J]. INDIAN JOURNAL OF UROLOGY, 2023, 39 (02) : 175 - 176
[4] Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer
Venkitaraman, R.
Cook, G. J. R.
Dearnaley, D. P.
Parker, C. C.
Khoo, V.
Eeles, R.
Huddart, R. A.
Horwich, A.
Sohaib, S. A.
[J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2009, 53 (03) : 241 - 247
[5] Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer
Dennis, Elizabeth R.
Jia, Xiaoyu
Mezheritskiy, Irina S.
Stephenson, Ryan D.
Schoder, Heiko
Fox, Josef J.
Heller, Glenn
Scher, Howard I.
Larson, Steven M.
Morris, Michael J.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) : 519 - 524
[6] Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer
El-Amm, Joelle
Aragon-Ching, Jeanny B.
[J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2016, 10 : 11 - 19
[7] Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy
Cascini, G.
Falcone, C.
Greco, C.
Bertucci, B.
Cipullo, S.
Tamburrini, O.
[J]. RADIOLOGIA MEDICA, 2008, 113 (08): : 1157 - 1170
[8] Excretion and whole-body retention of radium-223 dichloride administered for the treatment of bone metastases from castration resistant prostate cancer
Pratt, Brenda E.
Hindorf, Cecilia
Chittenden, Sarah J.
Parker, Christopher C.
Flux, Glenn D.
[J]. NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (02) : 125 - 130
[9] Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687
Muzi, Mark
O'Sullivan, Finbarr
Perk, Timothy G.
Muzi, John P.
Mankoff, David A.
Jeraj, Robert
Duan, Fenghai
Yu, Evan Y.
[J]. TOMOGRAPHY, 2021, 7 (02) : 139 - 153
[10] Therapeutic opportunities for castration-resistant prostate cancer patients with bone metastases
Zustovich, Fable
Fabiani, Francesca
[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 91 (02) : 197 - 209

← 1 2 3 4 5 →